CLSA

Ubrigene is driven by the advancement of gene and cell therapy technologies through research and development represented by AAV vectors. It can provide a comprehensive solution for gene therapy industrialization.

Rise Consulting Group, Inc. is a management and information technology consulting firm based in Tokyo, Japan, founded in 2012. The company specializes in a variety of consulting services, including digital consulting, fintech consulting, innovation consulting, and overseas expansion consulting. Additionally, it offers strategy consulting, business process re-engineering, and project management consulting to help clients enhance their operations and achieve their business objectives.

Know Your Customer Limited specializes in providing digital solutions for the identification and verification of both individual and corporate clients during the onboarding process. Founded in 2015 and headquartered in Wan Chai, Hong Kong, with additional offices in Dublin, Singapore, and Shanghai, the company offers services such as automated document collection, digital ID verification, and anti-money laundering checks across over 140 countries. Its technology automates 90% of routine compliance tasks, streamlining the KYC and AML functions for organizations in various sectors, including banking, financial technology, insurance, and real estate. By enhancing the accuracy and efficiency of compliance processes, Know Your Customer enables businesses to conduct thorough assessments while maintaining consistency across different jurisdictions.

Horizon Robotics is a prominent provider of advanced driver assistance systems (ADAS) and autonomous driving solutions specifically designed for passenger vehicles. The company develops proprietary software and hardware that integrate advanced algorithms and specialized processing capabilities. These technologies form the foundation for enhanced driving automation, aiming to improve both safety and the overall experience for drivers and passengers. By focusing on innovative solutions, Horizon Robotics plays a key role in the evolution of assisted and autonomous driving.

Formed in 2015, NWP Property is a joint venture between PT. Nirvana Development Tbk. (NIRO) and Warburg Pincus, formed to build and develop a best-in-class retail platform in Indonesia. The Venture focuses on developing hypermarket-anchored shopping malls in Indonesia to capitalize on the country’s growth potential which is driven by rapid urbanization, emerging consumption and outsized economic growth. This strategic partnership is founded on a common vision to expand NWP Property’s footprint across high potential areas for retail development throughout Indonesia.

Akili Interactive is a digital medicine company focused on developing innovative cognitive treatments using technology. The company has a diverse pipeline of programs designed to address cognitive deficiencies and alleviate symptoms associated with various medical conditions. These include attention-deficit hyperactivity disorder (ADHD), major depressive disorder (MDD), autism spectrum disorder (ASD), and several inflammatory diseases. By leveraging engaging digital platforms, Akili aims to improve patient outcomes in the fields of neurology and psychiatry through its unique therapeutic approaches.

Symphony Communication Services, LLC is a secure collaboration platform designed to enhance communication among traders and portfolio managers within financial institutions. The platform consolidates digital communications, including messaging, screen sharing, and audio/video conferencing, into a single, secure application. Symphony's offerings include tools for internal and external team communication, document sharing, and an application directory that supports various integrations and workflows. Tailored solutions are provided for sectors such as sales and trading, market research, portfolio management, and legal services, addressing the complex data security and regulatory compliance needs of the financial and insurance industries. Founded in 2012 and rebranded in 2014, Symphony is headquartered in Palo Alto, California, with additional offices in major financial hubs worldwide.

Azoya, established in 2013, is a prominent provider of turnkey e-commerce solutions that assists global brands and retailers in entering the Chinese market through cross-border e-commerce. The company specializes in various aspects of market entry, including IT, logistics, payment processing, merchandising, marketing, daily operations, and customer service. By offering comprehensive, cost-effective services, Azoya facilitates a low-risk approach for retailers looking to expand in China while managing the complexities associated with traditional market entry. It has successfully supported over 100 retailers and brands from more than 12 countries across diverse sectors, including beauty, health, and fashion. Azoya's global presence spans countries such as the United States, the United Kingdom, Germany, and Japan. The company collaborates with notable partners, including leading retailers like FragranceNet and FEELUNIQUE.com, and also engages in social community management through its AI-powered shopping guide app, AzoyaClub.

Hathway Broadband is India's leading internet service provider, serving you at superfast speeds. We are committed to converging the worlds of information and entertainment through reliable, high-speed web solutions.At Hathway Broadband, we are all set to change the way you surf the web. We are among the leading pioneers of DOCSIS 3.0, the latest international standard in internet technology which will allow our customers significantly faster internet speeds. Join the high-speed club, contact us today!

EVE offers massively multiplayer online roleplaying games. The company’s portfolio includes Eve Online, Eve Valkyrie, Gunjack, Dust 514, and Eve Universe.

EVE offers massively multiplayer online roleplaying games. The company’s portfolio includes Eve Online, Eve Valkyrie, Gunjack, Dust 514, and Eve Universe.

BioVex is a biotechnology company dedicated to developing and commercializing biological therapies for cancer treatment and the prevention of infectious diseases. Its primary focus is OncoVEXGM-CSF, an oncolytic vaccine that selectively targets and destroys cancer cells while sparing surrounding healthy tissue. This vaccine operates by replicating within solid tumors, leading to cancer cell death, and also stimulates a robust systemic immune response against tumors. OncoVEXGM-CSF has undergone clinical testing in over 110 patients across various solid tumors, including melanoma, head and neck cancer, breast cancer, and pancreatic cancer. The treatment has demonstrated significant efficacy, routinely eliminating tumors at the injection site and achieving overall disease responses during Phase II trials, with no reported recurrences of resolved tumors. Additionally, BioVex is developing ImmunoVEXHSV2, a vaccine aimed at preventing genital herpes.